Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Ruebel
A. Ruebel
Novartis
Treosulfan
Etoricoxib
Medicine
imatinib mesylate
Prostate cancer
3
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
2015
Cancer Microenvironment
Martin Vogelhuber
S. Feyerabend
A. Stenzl
T. Suedhoff
M. Schulze
J. Huebner
R. Oberneder
W.F. Wieland
S. Mueller
F Eichhorn
Hans Heinzer
K. Schmidt
M. Baier
A. Ruebel
Katrin Birkholz
A. Bakhshandeh-Bath
Reinhard Andreesen
Wolfgang Herr
Albrecht Reichle
Show All
Source
Cite
Save
Citations (7)
Redirecting and Modulating Rationalizations of Tumor-Immanent Normative Functions in Castration-Resistant Prostate Cancer
2013
Martin Vogelhuber
S. Feyerabend
A. Stenzl
T. Suedhoff
M. Schulze
J. Huebner
R. Oberneder
W.F. Wieland
S. Mueller
F Eichhorn
Hans Heinzer
K. Schmidt
M. Baier
A. Ruebel
Katrin Birkholz
A. Bakhshandeh-Bath
Reinhard Andreesen
Albrecht Reichle
Show All
Source
Cite
Save
Citations (0)
A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC).
2011
Journal of Clinical Oncology
Albrecht Reichle
Martin Vogelhuber
S. Feyerabend
T. Suedhoff
M. Schulze
J. Hübner
R. Oberneder
M. Baier
A. Ruebel
Katrin Birkholz
A. Bakhshandeh-Bath
Reinhard Andreesen
Show All
Source
Cite
Save
Citations (11)
1